Dual treatment of albendazole in hepatic hydatidosis: New therapeutic modality in 52 cases

Polat, C; Dervisoglu, A; Hokelek, Murat; Yetim, I; Buyukkarabacak, Y; Ozkutuk, Y; Erzurumlu, K

doi:10.1111/j.1440-1746.2004.03535.x

Dual treatment of albendazole in hepatic hydatidosis: New therapeutic modality in 52 cases

Copy For Citation

Polat C., Dervisoglu A., Hokelek M., Yetim I., Buyukkarabacak Y., Ozkutuk Y., ...More

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol.20, no.3, pp.421-425, 2005 (SCI-Expanded)

Publication Type: Article / Article
Volume: 20 Issue: 3
Publication Date: 2005
Doi Number: 10.1111/j.1440-1746.2004.03535.x
Journal Name: JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.421-425
Istanbul University Affiliated: No

Abstract

Background: Hepatic hydatidosis still remains as a serious problem in general surgery. Recurrence and/or secondary hydatidosis rates are up to 25% in the cases treated with surgery alone. Albendazole is the most commonly used drug in the medical treatment of echinococcosis. The aim of the present study was to evaluate the effect of albendazole using the intraoperative and perioperative periods as dual therapy.